NuVasive (NUVA) Reports In-Line Q2 EPS, Revenues Beat; Offers FY18 EPS Outlook Below Consensus

Go back to NuVasive (NUVA) Reports In-Line Q2 EPS, Revenues Beat; Offers FY18 EPS Outlook Below Consensus

NuVasive (NUVA) PT Lowered to $67 at Needham & Company

August 1, 2018 7:39 AM EDT

Needham & Company lowered its price target on NuVasive (NASDAQ: NUVA) to $67.00 (from $69.00) while maintaining a Buy rating as margins disappointed in Q2.

Analyst Mike Matson commented, "NUVA's 2Q18 revenue beat and EPS met consensus. Management reiterated its 2018 revenue guidance and lowered EPS guidance... More